Rachel McMinn, Chief Executive Officer at Neurogene Inc. (NGNE), sold 6,704 shares at $22.07 ($148K) on 2026-03-26, disclosed to the SEC on 2026-03-30.
Open-market sale of $148k NGNE by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.07 | 3,352 | $74K | 50.0% |
| 2 | $22.07 | 3,352 | $74K | 50.0% |
| Total | $22.07 avg | 6,704 | $148K | 100% |
| Filing → |
| ICPT | SELL | 2017-08-02 | $16K | — | Filing → |
| ICPT | SELL | 2017-07-05 | $31K | — | Filing → |
| ICPT | SELL | 2017-05-03 | $13K | — | Filing → |